An exploratory study on the anti-inflammatory effects of fucoidan in relation to quality of life in advanced cancer patients
Not Applicable
- Conditions
- advanced cancer
- Registration Number
- JPRN-UMIN000024066
- Lead Sponsor
- Kawaguchi Medical Clinic
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
with serious dysfunction of vital organs.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in inflammatory biomarkers including high-sensitivity CRP, and pro-inflammatory cytokines (IL-1beta, IL-6, TNF-alfa) during the study period of 4w.
- Secondary Outcome Measures
Name Time Method Changes in QOL scores using EORTC QLQ-C30 during the study period of 4w.